Earnings Week Ahead: JPM, JNJ, BAC, GS, C, UNH, TSM, and more

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Entering text into the input field will update the search result below

• Key themes include lending trends, net interest income, trading, investment banking activities, and consumer credit quality. Banks like JPMorgan and Bank of America are providing contrasting outlooks, with JPMorgan forecasting increased trading revenue and investment banking fees, while Bank of America expects a decline in its investment banking fees.
• Record revenues and an increase in capital expenditure and sales guidance are being driven by robust AI-related chip demand. TSMC's continued investments in advanced manufacturing like 2 nm nodes respond to rising customer interest from major clients such as Apple and plans for capacity expansion, maintaining strong analyst sentiment.
• Recent positive clinical trial results in oncology, immunology, and neuroscience—such as CARVYKTI, TREMFYA, and CAPLYTA—are supporting revenue expansion and driving up management’s full-year financial guidance, reinforcing positive analyst sentiment despite ongoing talc litigation risks.